Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
50,838,757
-
Share change
-
+2,797,731
-
Total reported value
-
$2,034,247,120
-
Put/Call ratio
-
195%
-
Price per share
-
$40.00
-
Number of holders
-
273
-
Value change
-
+$109,501,908
-
Number of buys
-
126
-
Number of sells
-
136
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2017
As of 30 Sep 2017,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) was held by
273 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,838,757 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., Bank of New York Mellon Corp, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, Champlain Investment Partners, LLC, RICE HALL JAMES & ASSOCIATES, LLC, and ROTHSCHILD ASSET MANAGEMENT INC.
This page lists
273
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.